Skip to content
★ Sign in to follow
BS
Total declarations
5
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€16k

Latest filing published 27 Oct 2016 for HAEMONETICS CORP, €121k.

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

No signal scores available.

Byron Selman: trading record in brief

Byron Selman is a declared insider of Haemonetics Corp, with filings sourced from SEC (Form 4). We count 5 filings; the first trade dates from 20 October 2015 and the latest from 25 October 2016.

Every open-market trade on record is a sale: 2 sales worth €16k. Outside the open market, there are 3 share grants.

The latest filing, published on 27 October 2016, reports a share grant of €121k in Haemonetics Corp. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Byron Selman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ◆
    President, Global MarketsExecutivesHaemonetics Corp
    131,230 USD30SEC
    3,836 shares@ US$34.21100.0% of flowCommon StockSEC:0001127602-16-065409:0
  • ◆
    President, Global MarketsExecutivesHaemonetics Corp
    0SEC
    8,138 sharesCommon StockSEC:0001127602-16-037237:0
  • ▼
    President, Global MarketsExecutivesHaemonetics Corp
    11,053 USD0SEC
    344 shares@ US$32.13Common StockSEC:0001127602-15-029708:0
  • ▼
    President, Global MarketsExecutivesHaemonetics Corp
    6,064 USD0SEC
    191 shares@ US$31.75Common StockSEC:0001127602-15-029619:0
  • ◆
    President, Global MarketsExecutivesHaemonetics Corp
    39 USD0SEC
    3,909 shares@ US$0.01Common StockSEC:0001127602-15-029496:0

5 of 5 declarations